These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population? Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447 [TBL] [Abstract][Full Text] [Related]
4. Prospective real-time evaluation of the QTc interval variation after low-dose droperidol among emergency department patients. Hernández-Rodríguez L; Bellolio F; Cabrera D; Mattson AE; VanMeter D; Grush AE; Oliveira J E Silva L Am J Emerg Med; 2022 Feb; 52():212-219. PubMed ID: 34959024 [TBL] [Abstract][Full Text] [Related]
5. Reviewing case reports and the droperidol warning: FDA response. Chang N; Simone A; Schultheis L; Rappaport B Anesth Analg; 2003 Nov; 97(5):1542. PubMed ID: 14570686 [No Abstract] [Full Text] [Related]
6. Droperidol for perioperative sedation causes a transient prolongation of the QTc time in children under volatile anesthesia. Stuth EA; Stucke AG; Cava JR; Hoffman GM; Berens RJ Paediatr Anaesth; 2004 Oct; 14(10):831-7. PubMed ID: 15385011 [TBL] [Abstract][Full Text] [Related]
7. Droperidol, QT prolongation, and sudden death: what is the evidence? Kao LW; Kirk MA; Evers SJ; Rosenfeld SH Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255 [TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study. White PF; Song D; Abrao J; Klein KW; Navarette B Anesthesiology; 2005 Jun; 102(6):1101-5. PubMed ID: 15915020 [TBL] [Abstract][Full Text] [Related]
12. There should be a threshold dose for the FDA black-box warning on droperidol. Habib AS; Gan TJ Anesth Analg; 2003 Nov; 97(5):1543. PubMed ID: 14570685 [No Abstract] [Full Text] [Related]
14. Arrhythmias from droperidol? Med Lett Drugs Ther; 2002 Jun; 44(1132):53-4. PubMed ID: 12058151 [No Abstract] [Full Text] [Related]
15. FDA response to droperidol black box warning editorials. Rappaport BA Anesth Analg; 2008 May; 106(5):1585. PubMed ID: 18420886 [No Abstract] [Full Text] [Related]
16. Sufficiency of data for resuming use of low-dose droperidol. Wyllie AR; Carvalhana VV; Burry LD; Teresi JE Am J Health Syst Pharm; 2008 Feb; 65(3):201. PubMed ID: 18216002 [No Abstract] [Full Text] [Related]
18. Pro: The Food and Drug Administration Black box warning on droperidol is not justified. Habib AS; Gan TJ Anesth Analg; 2008 May; 106(5):1414-7. PubMed ID: 18420854 [No Abstract] [Full Text] [Related]
19. Con: The black box warning on droperidol should not be removed (but should be clarified!). Ludwin DB; Shafer SL Anesth Analg; 2008 May; 106(5):1418-20. PubMed ID: 18420855 [No Abstract] [Full Text] [Related]
20. Drug-induced prolongation of the QT interval: what's the point? White PF; Abrao J Anesthesiology; 2006 Feb; 104(2):386-7. PubMed ID: 16436877 [No Abstract] [Full Text] [Related] [Next] [New Search]